tolbutamide has been researched along with glutamic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Abramets, II; Komissarov, IV; Samoĭlovich, IM | 1 |
| Bernardi, G; Calabresi, P; Centonze, D; Pisani, A | 1 |
| Ballanyi, K; Kulik, A; Trapp, S | 1 |
| Hasnain, S; Krupa, JC; Ménard, R; Mort, JS; Nägler, DK | 1 |
| Bertrand, G; Henquin, JC; Ishiyama, N; Nenquin, M; Ravier, MA | 1 |
| Bancila, V; Bloc, A; Dunant, Y; Nikonenko, I | 1 |
7 other study(ies) available for tolbutamide and glutamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Postsynaptic metabolic monoamine modulation of effects mediated by NMDA glutamate receptors in spinal motoneurons of the frog].
Topics: Animals; Biogenic Amines; Evoked Potentials; Glutamates; Glutamic Acid; Membrane Potentials; Motor Neurons; Ranidae; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord; Synapses; Tolbutamide; Trifluoperazine | 1991 |
Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses.
Topics: Adenosine; Animals; Caffeine; Cerebral Cortex; Corpus Striatum; Evoked Potentials; Glipizide; Glucose; Glutamic Acid; Hypoglycemic Agents; In Vitro Techniques; Membrane Potentials; Neurons; Potassium Channel Blockers; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synapses; Theophylline; Tolbutamide; Xanthines | 1997 |
Ischemia but not anoxia evokes vesicular and Ca(2+)-independent glutamate release in the dorsal vagal complex in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Brain Ischemia; Brain Stem; Calcium; Chloride Channels; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Hypoglycemic Agents; Hypoxia, Brain; In Vitro Techniques; Indoles; Male; Neurons; Patch-Clamp Techniques; Rats; Rats, Wistar; Sulfonylurea Compounds; Synaptic Transmission; Tolbutamide; Vagus Nerve | 2000 |
S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.
Topics: Amidohydrolases; Aspartic Acid; Binding Sites; Cathepsin B; Exopeptidases; Glutamic Acid; Histidine; Humans; Ions; Kinetics; Lysosomes; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Substrate Specificity; Tolbutamide | 2002 |
The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related.
Topics: Allosteric Site; Amino Acids, Cyclic; Animals; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Exocytosis; Female; Glucose; Glutamic Acid; Hydrogen-Ion Concentration; Insulin; Insulin Secretion; Male; Mice; Pancreas; Potassium; Potassium Chloride; Protein Binding; Rats; Rats, Wistar; Time Factors; Tolbutamide | 2002 |
Zinc inhibits glutamate release via activation of pre-synaptic K channels and reduces ischaemic damage in rat hippocampus.
Topics: 4-Aminopyridine; Animals; Animals, Newborn; Brain Ischemia; Chelating Agents; Chlorocebus aethiops; COS Cells; Drug Interactions; Edetic Acid; Glutamic Acid; Gramicidin; Hippocampus; Ionophores; Luminescent Measurements; Male; Membrane Proteins; Microscopy, Electron; Mossy Fibers, Hippocampal; Organ Culture Techniques; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Presynaptic Terminals; Rats; Rats, Wistar; Synaptosomes; Time Factors; Tolbutamide; Transfection; Valinomycin; Zinc | 2004 |